CN111377894B - 一种3-n-丁基-l(3H)-异苯并呋喃酮的纯化方法 - Google Patents
一种3-n-丁基-l(3H)-异苯并呋喃酮的纯化方法 Download PDFInfo
- Publication number
- CN111377894B CN111377894B CN201811639440.6A CN201811639440A CN111377894B CN 111377894 B CN111377894 B CN 111377894B CN 201811639440 A CN201811639440 A CN 201811639440A CN 111377894 B CN111377894 B CN 111377894B
- Authority
- CN
- China
- Prior art keywords
- butyl
- isobenzofuranone
- purification method
- purification
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 title claims abstract description 103
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000000746 purification Methods 0.000 title claims abstract description 26
- 239000012043 crude product Substances 0.000 claims abstract description 20
- 239000003960 organic solvent Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000012074 organic phase Substances 0.000 claims abstract description 4
- 239000007864 aqueous solution Substances 0.000 claims description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000007818 Grignard reagent Substances 0.000 claims description 9
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- DYNFCHNNOHNJFG-UHFFFAOYSA-N 2-formylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=O DYNFCHNNOHNJFG-UHFFFAOYSA-N 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- -1 n-butyl Grignard reagent Chemical class 0.000 claims description 6
- 239000012445 acidic reagent Substances 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- QUXHCILOWRXCEO-UHFFFAOYSA-M magnesium;butane;chloride Chemical group [Mg+2].[Cl-].CCC[CH2-] QUXHCILOWRXCEO-UHFFFAOYSA-M 0.000 claims description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940011051 isopropyl acetate Drugs 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000005292 vacuum distillation Methods 0.000 abstract description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 21
- 239000012535 impurity Substances 0.000 description 13
- 239000002253 acid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 150000004795 grignard reagents Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- WMBOCUXXNSOQHM-FLIBITNWSA-N (Z)-3-butylidenephthalide Chemical compound C1=CC=C2C(=C/CCC)/OC(=O)C2=C1 WMBOCUXXNSOQHM-FLIBITNWSA-N 0.000 description 2
- WMBOCUXXNSOQHM-DHZHZOJOSA-N 3-Butylidenephthalide Natural products C1=CC=C2C(=C/CCC)\OC(=O)C2=C1 WMBOCUXXNSOQHM-DHZHZOJOSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- WMBOCUXXNSOQHM-UHFFFAOYSA-N n-butylidenephthalide Natural products C1=CC=C2C(=CCCC)OC(=O)C2=C1 WMBOCUXXNSOQHM-UHFFFAOYSA-N 0.000 description 2
- 230000007971 neurological deficit Effects 0.000 description 2
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- SWAMOIJQDQZLRX-UHFFFAOYSA-N 2-pentanoylbenzoic acid Chemical compound CCCCC(=O)C1=CC=CC=C1C(O)=O SWAMOIJQDQZLRX-UHFFFAOYSA-N 0.000 description 1
- 244000101724 Apium graveolens Dulce Group Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- MXLGRISHDPOJIM-UHFFFAOYSA-M [Cl-].CCCC[Mg+].C1CCOC1 Chemical compound [Cl-].CCCC[Mg+].C1CCOC1 MXLGRISHDPOJIM-UHFFFAOYSA-M 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 125000005506 phthalide group Chemical group 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811639440.6A CN111377894B (zh) | 2018-12-29 | 2018-12-29 | 一种3-n-丁基-l(3H)-异苯并呋喃酮的纯化方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811639440.6A CN111377894B (zh) | 2018-12-29 | 2018-12-29 | 一种3-n-丁基-l(3H)-异苯并呋喃酮的纯化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111377894A CN111377894A (zh) | 2020-07-07 |
CN111377894B true CN111377894B (zh) | 2023-10-20 |
Family
ID=71213036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811639440.6A Active CN111377894B (zh) | 2018-12-29 | 2018-12-29 | 一种3-n-丁基-l(3H)-异苯并呋喃酮的纯化方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111377894B (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101962374A (zh) * | 2010-10-21 | 2011-02-02 | 上海应用技术学院 | 一种芹菜甲素的制备方法 |
CN105367526A (zh) * | 2015-10-14 | 2016-03-02 | 济南诚汇双达化工有限公司 | 一种高纯度正丁基苯酞的制备方法 |
CN105418564A (zh) * | 2015-08-21 | 2016-03-23 | 石药集团恩必普药业有限公司 | 一种丁苯酞新的预处理方法 |
CN105859670A (zh) * | 2016-04-19 | 2016-08-17 | 丽珠医药集团股份有限公司 | 一种高纯度丁苯酞的制备方法 |
CN105884726A (zh) * | 2015-01-16 | 2016-08-24 | 海门慧聚药业有限公司 | 丁苯酞的合成方法和纯化工艺 |
CN107216298A (zh) * | 2017-07-24 | 2017-09-29 | 北京科莱博医药开发有限责任公司 | 一种丁苯酞的制备方法 |
CN107235943A (zh) * | 2017-07-24 | 2017-10-10 | 北京科莱博医药开发有限责任公司 | 一种高纯度丁苯酞的制备方法 |
CN108623456A (zh) * | 2017-03-16 | 2018-10-09 | 齐鲁制药有限公司 | 丁苯酞及其药物中间体的制备方法 |
-
2018
- 2018-12-29 CN CN201811639440.6A patent/CN111377894B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101962374A (zh) * | 2010-10-21 | 2011-02-02 | 上海应用技术学院 | 一种芹菜甲素的制备方法 |
CN105884726A (zh) * | 2015-01-16 | 2016-08-24 | 海门慧聚药业有限公司 | 丁苯酞的合成方法和纯化工艺 |
CN105418564A (zh) * | 2015-08-21 | 2016-03-23 | 石药集团恩必普药业有限公司 | 一种丁苯酞新的预处理方法 |
CN105367526A (zh) * | 2015-10-14 | 2016-03-02 | 济南诚汇双达化工有限公司 | 一种高纯度正丁基苯酞的制备方法 |
CN105859670A (zh) * | 2016-04-19 | 2016-08-17 | 丽珠医药集团股份有限公司 | 一种高纯度丁苯酞的制备方法 |
CN108623456A (zh) * | 2017-03-16 | 2018-10-09 | 齐鲁制药有限公司 | 丁苯酞及其药物中间体的制备方法 |
CN107216298A (zh) * | 2017-07-24 | 2017-09-29 | 北京科莱博医药开发有限责任公司 | 一种丁苯酞的制备方法 |
CN107235943A (zh) * | 2017-07-24 | 2017-10-10 | 北京科莱博医药开发有限责任公司 | 一种高纯度丁苯酞的制备方法 |
Non-Patent Citations (2)
Title |
---|
3-取代-1(3H)-异苯并呋喃酮光学异构体的合成及抗血小板活性初步研究;杨华等;《中南药学》;20070920;第05卷(第05期);第433-437页 * |
正丁基苯酞的合成及结构表征;高奥等;《广东药学院学报》;20130625;第29卷(第03期);第250-252页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111377894A (zh) | 2020-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105884726B (zh) | 丁苯酞的合成方法和纯化工艺 | |
CN109081822B (zh) | 一种简便制备高纯度丁苯酞的方法 | |
CN105859670B (zh) | 一种高纯度丁苯酞的制备方法 | |
CN113248467A (zh) | 一种西瓜酮的制备方法 | |
CN114292256A (zh) | 一种适用于工业化生产的西瓜酮粗品制备方法及提纯方法 | |
CN102453011A (zh) | 一种高纯度柚皮素的制备方法 | |
WO2010109650A1 (ja) | 3-メチル-シクロペンタデセノン類の製造方法、r/s-ムスコンの製造方法および光学活性ムスコンの製造方法 | |
CN102391128B (zh) | 一种抗生素医药中间体丙二酸单对硝基苄酯的生产方法 | |
CN111377894B (zh) | 一种3-n-丁基-l(3H)-异苯并呋喃酮的纯化方法 | |
CN110078672B (zh) | 高纯度的2,4-二氯-5-氟嘧啶制备方法 | |
CN107935971B (zh) | 一种(s)-3-羟基四氢呋喃的制备方法 | |
CN106631991B (zh) | 一种n-丁基-2,2,6,6-四甲基-4-哌啶胺的简便合成方法 | |
CN113024495B (zh) | 一种丁苯酞新的提纯方法 | |
CN111377893B (zh) | 一种3-n-丁基-l(3H)-异苯并呋喃酮的合成方法 | |
CN110317170B (zh) | 一种3-菲啶基甲酸丙酯类化合物的绿色合成方法 | |
CN108203421B (zh) | 制备丁苯酞的工艺 | |
CN103709092B (zh) | 米格列奈钙的制备方法 | |
CN103360217B (zh) | 制备s-(-)-1,1-二苯基-1,2-丙二醇的方法 | |
CN109400555B (zh) | 一种α-乙酰基-γ-丁内酯钠盐游离盐酸乙脒工艺 | |
CN116396252A (zh) | 一种高纯度丁苯酞的制备方法 | |
CN107216294B (zh) | 含α-哌啶的生物碱中间体及制备方法 | |
CN109232465B (zh) | 一种噁草酮结晶母液催化法制备噁草酮酚的方法 | |
CN109608296B (zh) | 一种环丙乙炔的新型制备方法 | |
CN115745930A (zh) | 一种丁苯酞的制备方法 | |
CN114685410B (zh) | 一种丁苯酞的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240511 Address after: No. 699-18 Xuanwu Avenue, Xuanwu District, Nanjing City, Jiangsu Province Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Country or region after: China Address before: 210042 699 Xuanwu Road, Xuanwu District, Nanjing, Jiangsu -18 Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Country or region before: China Patentee before: SHANDONG SIMCERE BIO-PHARMACEUTICAL Co.,Ltd. |